Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 94 | 3,491 | 0 | 90 | 7,617 |
| Gross Profit | 94 | 3,491 | N/A | 90 | 7,617 |
| Operating Expenses | 2,184 | 1,946 | 2,631 | 3,382 | 4,395 |
| Operating Income | -2,090 | 1,546 | -2,631 | -3,293 | 3,223 |
| Other Income | 226 | 237 | 412 | 224 | 291 |
| Pre-tax Income | -1,865 | 1,782 | -2,219 | -3,068 | 3,514 |
| Income Tax | 0 | 0 | N/A | -1 | 0 |
| Net Income Continuous | -1,865 | 1,782 | -2,219 | -3,068 | 3,514 |
| Net Income | $-1,865 | $1,782 | $-2,219 | $-3,069 | $3,514 |
| EPS Basic Total Ops | -0.35 | 0.32 | -0.41 | -0.57 | 0.66 |
| EPS Basic Continuous Ops | -0.35 | 0.33 | -0.41 | -0.57 | 0.66 |
| EPS Diluted Total Ops | -0.35 | 0.35 | -0.44 | -0.57 | 0.66 |
| EPS Diluted Continuous Ops | -0.35 | 0.33 | -0.41 | -0.57 | 0.66 |
| EPS Diluted Before Non-Recurring Items | -0.35 | 0.33 | -0.44 | N/A | N/A |
| EBITDA(a) | $-2,133 | $1,443 | $-2,790 | $-3,480 | $3,016 |